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Background: This study was designed to determine the optimal sedative dose of propofol to start brain magnetic 
resonance imaging (MRI) in children with cerebral palsy (CP). 
Methods: Twenty children, aged 0.5-5 years, were administered propofol to achieve a University of Michigan 
Sedation Scale (UMSS) score ≥ 3 in the MRI room. The proper dose of propofol was determined using the up-and-
down method. 
Results: The ED50 and ED95 for successful sedation with a UMSS ≥ 3 were 2.07 mg/kg (95% CI 1.69-2.56) and 2.69 
mg/kg (95% CI 2.35-5.59). Respiratory events occurred in 5 patients and were resolved with neck extension, chin lift, 
or transient respiratory assistance with successful sedation.
Conclusions: Low dose propofol can safely facilitate the initiation of MRI in children with CP. (Korean J Anesthesiol 
2011; 61: 216-219)
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Introduction
Cerebral palsy (CP) is the general term for a group of non-
pro gressive but often changing motor impairment syndromes 
secondary to early brain development disorders. Clinical 
features may vary from mild monoplegia with normal intellect 
to severe body spasticity and mental retardation. Two neuro-
imaging studies reported that 70% and 90% of children with 
CP showed brain abnormalities [1,2]. Thus, MRI is a part of 
the routine investigation performed for a precise evaluation 
of children with CP. MRI requires complete immobility for 
accurate imaging during examination. Particularly in CP with 
spasticity or athetosis, deep sedation is required to control 
behaviour [3]. 
Propofol is a popular hypnotic agent for pediatric sedation 
because of its rapid onset, effective anaesthesia, rapid and 
complete recovery, and prevention of nausea and vomiting [4-7]. 
Children with CP have shown a drug response that is different 
from normal children, possibly related to an interaction 
with various oral medications such as baclofen, tizanidine, 
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diazepam, dantrolene, or anticonvulsant drugs [8,9].
We hypothesized that CP children may require less propofol 
than non-CP children for proper sedation during MRI. The 
aim of this study is to establish the optimal induction dose of 
propofol for deep sedation to start MRI for less than 30 min in 
children with CP. 
Materials and Methods
This study was approved by the institutional review board 
of our hospital and registered with clinicaltrial.gov. Written 
informed consent was obtained from all eligible participants’ 
parents for this study. Children with obstructive sleep apnea, 
anticipated difficult airway, evidence of cardiopulmonary 
disease, or allergic history to propofol were excluded from this 
study. 
Inclusion criteria were ASA status I or II with CP, aged 6 
months to 5 years, scheduled for brain MRI under sedation. 
No child was premedicated. After intravenous (IV) access was 
established by an expert nurse in the preparation room, children 
were transferred to the MRI room with their parents. After 
obtaining an electrocardiogram and measuring noninvasive 
blood pressure and pulse oximetry, a predetermined dosage 
of propofol mixed with lidocaine 2 mg/ml was administered 
over 30 s through the IV. An anesthesiologist blinded to the 
study protocol assessed the sedation level using a University of 
Michigan Sedation Scale (UMSS) (Table 1). If the child showed 
a UMSS score ≥3 after 1 min of propofol i.v. and showed no 
movement at the beginning of MRI examination, the case 
was considered successful sedation. If the child showed a 
score <3, required a titrated additional dose of propofol to 
deepen the sedation, then the case was considered a failed 
case. The modified Dixon’s up-and-down method by Paul and 
Fisher [10,11] was used to determine the propofol ED50 for 
appropriate sedation to start the MRI examination. The up-and-
down method required six independent pairs of consecutive 
subjects in which a success score followed by a failure score was 
obtained. The initial propofol dose was 2 mg/kg. If the sedation 
failed with the initial dose, propofol was increased by 0.5 mg/
kg for the next child. If the sedation was successful, the next 
patient received a propofol dose decreased by 0.5 mg/kg. The 
ED50 of propofol for a UMSS score >3 was defined by averaging 
the mid-point dose of all independent pairs of patients invol-
ving a crossover. Therefore, the number of patients was not 
determined prior to this study. 
A soft roll was placed under the patient’s shoulder to slightly 
extend the neck. Supplemental oxygen was given by a trans-
parent face mask at a flow rate of 5 L/min. End-expiratory 
carbon dioxide (ETCO2) was monitored via a nasal prong. 
Adequate spontaneous respiration without an artificial airway 
was established before examination. ECG, peripheral oxygen 
saturation (SpO2), and ETCO2 were monitored continuously, 
and noninvasive blood pressure was measured at 5-min 
intervals throughout the procedure. In cases of inadequate 
sedation during MRI, an additional 0.5 mg/kg of propofol was 
administered intermittently. 
After MRI examination, the patient was transferred to the 
sedation room with supplemental oxygen and pulse oximetry. 
During recovery, a blinded observer evaluated side effects such 
as oxygen desaturation, emergence agitation, postoperative 
nausea, and vomiting. When the children met the discharge 
criteria, they were discharged from the recovery room. A 
telephone interview was performed to determine the presence 
of any abnormal behaviour, fever, nausea, or vomiting during 
the first 24 hours. 
Statistical analysis was performed using PASW Statistics 18Ⓡ
(SPSS Inc, Chicago, IL, USA). Data are expressed as the mean 
± SD or the number of patients (%). The ED50 of propofol for 
tracheal intubation was defined by averaging the mid-point 
dose of all independent pairs of patients involving a crossover. 
The “up-and-down” data were also analyzed by a probit analysis, 
which enabled us to derive the mean propofol dose with a 95% 
confidence interval. A P value < 0.05 was considered signi-
ficant. 
Results
One patient was excluded from data analysis because keta-
mine was used during examination. The patients’ characteristics 
and outcomes during MRI scanning are presented in Table 2. 
Four children had ataxia, seven had athetosis, and nine had 
a spastic type of CP. Four of the 20 children had taken anti-
convulsants (carbamazepine, clonazepam, sodium valproate, 
or topiramate), and one had used anticholinergic drug (oxy-
butynin). All children had abnormal results in official readings 
of their brain MRI. 
The sequence of successful and unsuccessful induction 
of deep sedation is shown in Fig. 1. The ED50 and ED95 for 
successful sedation with UMSS ≥3 were 2.07 mg/kg (95% CI 
Table 1. The University of Michigan Sedation Scale (UMSS)
Value Patient state
0
1
2
3
4
Awake and alert
Minimally sedated: tired/sleepy, appropriate response to 
verbal conversation, and/or sound
Moderately sedated: somnolent/sleeping, easily aroused 
with light tactile stimulation or a simple verbal command
Deeply sedated: deep sleep, aroused only with significant 
physical stimulation
Unarousable
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1.69-2.56) and 2.69 mg/kg (95% CI 2.35-5.59), respectively. 
Immediately after propofol injection, respiratory events 
(desaturation <95% and partial airway obstruction) occurred 
in five patients with successful sedation (SpO2 <95% in four 
and <85% in one), which were promptly resolved with a neck 
extension, chin lift, or transient respiratory assistance. No other 
adverse events such as hypotension, bradycardia, or arrhythmia 
were observed during the MRI examination. All scheduled MRI 
examinations were successfully completed within 30 minutes. 
In 10 children, additional propofol was administered. No one 
showed emergence agitation, abnormal behaviour, fever, or 
nausea and vomiting during recovery after sedation or in the 
first 24 h after discharge. 
Discussion
The goals of sedation in children for diagnostic and therap-
eutic procedures are to (1) guard their patients’ safety and 
welfare; (2) minimize physical discomfort and pain; (3) control 
anxiety, minimize psychological trauma, and maximize the 
potential for amnesia; (4) control behaviour and or movement 
to allow safe completion of the procedure; and (5) return the 
patient to a state in which safe discharge from medical super-
vision, as determined by recognized criteria, is possible [12]. 
These goals can best be achieved by selecting the lowest dose of 
a drug with the highest therapeutic index for the procedure.
Children with CP may demonstrate a decreased MAC of 
volatile anaesthetics when compared to healthy children (e.g. 
the MAC of halothane has been shown to be 20% lower) [8]. The 
MAC of halothane may be further lowered in children with CP 
taking anticonvulsants for seizure disorders [8]. In a study using 
BIS, the propofol dosage for a BIS value of 35-45 was also lower 
in children with CP than in healthy children (3.29 ± 0.5 mg/kg 
vs. 3.6 ± 0.9 mg/kg) [9]. However, no difference was found in 
their study between the propofol dosages of CP children using 
seizure medication and those who were not. We did not exclude 
children who had taken seizure medication, but we could not 
verify whether the seizure medication had any affect on the 
propofol dosage for deep sedation. Our results showed that 
the ED50 and ED95 of propofol for successful deep sedation 
to perform MRI were 2.07 mg/kg (95% CI 1.69-2.56) and 2.69 
mg/kg (95% CI 2.35-5.95), respectively, in children with CP. 
The mean total dose of propofol was 3.2 ± 0.9 mg/kg, which was 
higher than the 2.4 ± 0.7 mg/kg results of a study performed in 
children who underwent MRI for less than 30 min by Cho et al. 
[13]. Cho et al. enrolled children with various cause (delayed 
development, seizure, cerebral palsy, brain tumor, etc.in their 
study, while we enrolled children with CP. For this study, we 
hypothesized that CP children may require less propofol than 
non-CP children for proper sedation during MRI. In our study, 
16 children had behavioural disturbances (7 were athetotic and 
9 were spastic). We obtained results that were the opposite of 
our hypothesis for the propofol dosage needed to get a sedation 
level ≥UMSS 3. Considering these results, we can presume that 
more propofol was required to get proper sedation in children 
with behavioural disturbances, while a lower dose of propofol 
was required in children with CP than in children without CP 
during induction of anesthesia [9]. Sometimes, propofol alone 
does not seem to suppress unintentional movements during 
sedation, as was the case in a study where a large dose of 
propofol (3.9 mg/kg, 1.8-6.4) was used to induce deep sedation 
without unintentional movements during MRI examination in 
children [14]. However, a large dosage of propofol can induce 
severe respiratory depression, and children may quickly move 
from one level of sedation to another. Furthermore, MRI-
compatible BIS or other monitors for sedation assessment are 
not yet available in practice. Therefore, the dosage of propofol 
must be carefully titrated with close observational scaling 
of the sedation level during MRI. In our study, the sedation 
Fig. 1. Responses of the 20 consecutive children for whom sedation 
for MRI scanning was attempted and the propofol concentration. 
Each patient’s data are represented by a circle.
Table 2. Patient Characteristics and Outcome Measures
N 20
Age (months)
Weight (kg)
Height (cm)
Sex (M/F)
Seizure medication 
MRI scanning time (min)
Recovery time (min)
Children requiring additional propofol (n)
Total dose of propofol (mg/kg)
28.7 ± 17.8
10.3 ± 4.6
82.6 ± 10.8
16/4
    4/20
26.3 ± 4.0
19.8 ± 9.4
10
3.2 ± 0.9
Values are the mean ± SD, the median (range), or the number of 
patients. 
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level was assessed by an anesthesiologist well-experienced 
at using the UMSS. We defined successful deep sedation as 
when the children showed a UMSS ≥3, in deep sleep, aroused 
only with significant physical stimulation. A UMSS ≥3 may be 
deep sedation, inducing respiratory depression. In our study, 
SpO2 was decreased (<95%) in 5 children with successful deep 
sedation (5/20, 25%) after propofol injection, but the problems 
were soon resolved with proper management. 
To determine the ED95 of the drug, logistic regression is 
commonly used. However, the up-and-down approach for 
analysis of quantal data may yield incorrect estimates. We used 
the modified Dixon’s up-and-down method, with a modi-
fication by Paul and Fisher [11], aiming for 6 crossovers in order 
to decrease the likelihood of reporting an inaccurate estimate. 
Nevertheless, the up-and-down method does not provide 
reliable insight into the upper tail of the distribution, and the 
assumption that the dose-response curve of the drug is well-
fitted by a symmetric logistic curve remains unverified [15]. This 
is a limitation of our study in defining the ED95 of propofol for 
sedation of children with CP. 
In summary, the ED50 and ED95 of propofol were 2.07 mg/
kg (95% CI 1.69-2.56) and 2.69 mg/kg (95% CI 2.35-5.95), 
respectively, for successful deep sedation with a UMSS score >3 
to start MRI in children with CP. 
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